Related Experiment Video
Updated: Aug 24, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
[Apheresis in severe hypercholesterolaemia]
Asgeir Graesdal1, Anders Hovland, Eyvind Bjørbaek
1Lipidklinikken Nordlandssykehuset, Bodø. asg3@hotmail.com
Background:
Hypercholesterolaemia is usually successfully treated with statins but in some cases the medication has insufficient cholesterol-lowering effect or is not well tolerated. In these instances LDL apheresis is an option.
Material And Methods:
We share some of our own experience with this treatment and then review the literature regarding LDL apheresis.
Results:
LDL apheresis seems a safe and effective way of lowering LDL cholesterol. Mortality and morbidity is reduced in selected patient groups. Quite probably, too few Norwegian patients are offered this treatment.
Interpretation:
LDL apheresis should be available in all health regions of Norway and the treatment should be known to all those who treat severe hypercholesterolaemia or coronary artery disease.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis III: Management
Lipids: Dietary Sources and Requirements
Atherosclerosis IV: Nursing Management
Cholecystitis